Authors’ response: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP

Eitemau Tebyg

• Authors’ response: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP
  gan: on behalf of the authors of the original article
  Cyhoeddwyd: (2026-01-01)
• Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort
  gan: Erin E. Cooney, PhD, MSPH, et al.
  Cyhoeddwyd: (2025-04-01)
• Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study
  gan: Giulia Del Duca, et al.
  Cyhoeddwyd: (2026-02-01)
• Navigating patterns of oral PrEP use: A qualitative longitudinal study of gay, bisexual, and queer men's dynamic practices of pausing, on-demand, and stopping PrEP in Canada
  gan: Emerich Daroya, et al.
  Cyhoeddwyd: (2024-06-01)
• Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the United States
  gan: Brooke G. Rogers, et al.
  Cyhoeddwyd: (2023-08-01)